CM
Therapeutic Areas
AltrixBio Pipeline
| Drug | Indication | Phase |
|---|---|---|
| AJN003 (LuCI™) | Type 2 Diabetes | Pre-clinical |
| AJN003 Platform | Obesity / Weight Management | Pre-clinical |
Leadership Team at AltrixBio
DP
David Pass
CEO and President
NB
Nancy Briefs
Co-Founder & Executive Chair of the Board
AT
Ali Tavakkoli
Co-Founder
JK
Jeff Karp
Co-Founder
JL
John L Brooks
Board Member
JP
Juan Pablo Frías
Clinical Advisory Board Member
MH
Michael Horowitz
Clinical Advisory Board Member